Considerations for standardizing predictive molecular pathology for cancer prognosis

Michelangelo Fiorentino, Marina Scarpelli, Antonio Lopez-Beltran, Liang Cheng, Rodolfo Montironi

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Introduction: Molecular tests that were once ancillary to the core business of cyto-histopathology are becoming the most relevant workload in pathology departments after histopathology/cytopathology and before autopsies. This has resulted from innovations in molecular biology techniques, which have developed at an incredibly fast pace. Areas covered: Most of the current widely used techniques in molecular pathology such as FISH, direct sequencing, pyrosequencing, and allele-specific PCR will be replaced by massive parallel sequencing that will not be considered next generation, but rather, will be considered to be current generation sequencing. The pre-analytical steps of molecular techniques such as DNA extraction or sample preparation will be largely automated. Moreover, all the molecular pathology instruments will be part of an integrated workflow that traces the sample from extraction to the analytical steps until the results are reported; these steps will be guided by expert laboratory information systems. In situ hybridization and immunohistochemistry for quantification will be largely digitalized as much as histology will be mostly digitalized rather than viewed using microscopy. Expert commentary: This review summarizes the technical and regulatory issues concerning the standardization of molecular tests in pathology. A vision of the future perspectives of technological changes is also provided.

Original languageEnglish (US)
Pages (from-to)47-55
Number of pages9
JournalExpert Review of Molecular Diagnostics
Volume17
Issue number1
DOIs
StatePublished - Jan 2 2017

Fingerprint

Molecular Pathology
Clinical Laboratory Information Systems
Pathology
Workflow
Workload
In Situ Hybridization
Molecular Biology
Microscopy
Autopsy
Neoplasms
Histology
Immunohistochemistry
Alleles
Polymerase Chain Reaction
DNA

Keywords

  • laboratory automation
  • molecular pathology
  • molecular pathology standardization
  • Molecular tests
  • regulations

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Considerations for standardizing predictive molecular pathology for cancer prognosis. / Fiorentino, Michelangelo; Scarpelli, Marina; Lopez-Beltran, Antonio; Cheng, Liang; Montironi, Rodolfo.

In: Expert Review of Molecular Diagnostics, Vol. 17, No. 1, 02.01.2017, p. 47-55.

Research output: Contribution to journalReview article

Fiorentino, Michelangelo ; Scarpelli, Marina ; Lopez-Beltran, Antonio ; Cheng, Liang ; Montironi, Rodolfo. / Considerations for standardizing predictive molecular pathology for cancer prognosis. In: Expert Review of Molecular Diagnostics. 2017 ; Vol. 17, No. 1. pp. 47-55.
@article{339f7bdf6835420d936dcfcc365b8bc2,
title = "Considerations for standardizing predictive molecular pathology for cancer prognosis",
abstract = "Introduction: Molecular tests that were once ancillary to the core business of cyto-histopathology are becoming the most relevant workload in pathology departments after histopathology/cytopathology and before autopsies. This has resulted from innovations in molecular biology techniques, which have developed at an incredibly fast pace. Areas covered: Most of the current widely used techniques in molecular pathology such as FISH, direct sequencing, pyrosequencing, and allele-specific PCR will be replaced by massive parallel sequencing that will not be considered next generation, but rather, will be considered to be current generation sequencing. The pre-analytical steps of molecular techniques such as DNA extraction or sample preparation will be largely automated. Moreover, all the molecular pathology instruments will be part of an integrated workflow that traces the sample from extraction to the analytical steps until the results are reported; these steps will be guided by expert laboratory information systems. In situ hybridization and immunohistochemistry for quantification will be largely digitalized as much as histology will be mostly digitalized rather than viewed using microscopy. Expert commentary: This review summarizes the technical and regulatory issues concerning the standardization of molecular tests in pathology. A vision of the future perspectives of technological changes is also provided.",
keywords = "laboratory automation, molecular pathology, molecular pathology standardization, Molecular tests, regulations",
author = "Michelangelo Fiorentino and Marina Scarpelli and Antonio Lopez-Beltran and Liang Cheng and Rodolfo Montironi",
year = "2017",
month = "1",
day = "2",
doi = "10.1080/14737159.2017.1266258",
language = "English (US)",
volume = "17",
pages = "47--55",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Considerations for standardizing predictive molecular pathology for cancer prognosis

AU - Fiorentino, Michelangelo

AU - Scarpelli, Marina

AU - Lopez-Beltran, Antonio

AU - Cheng, Liang

AU - Montironi, Rodolfo

PY - 2017/1/2

Y1 - 2017/1/2

N2 - Introduction: Molecular tests that were once ancillary to the core business of cyto-histopathology are becoming the most relevant workload in pathology departments after histopathology/cytopathology and before autopsies. This has resulted from innovations in molecular biology techniques, which have developed at an incredibly fast pace. Areas covered: Most of the current widely used techniques in molecular pathology such as FISH, direct sequencing, pyrosequencing, and allele-specific PCR will be replaced by massive parallel sequencing that will not be considered next generation, but rather, will be considered to be current generation sequencing. The pre-analytical steps of molecular techniques such as DNA extraction or sample preparation will be largely automated. Moreover, all the molecular pathology instruments will be part of an integrated workflow that traces the sample from extraction to the analytical steps until the results are reported; these steps will be guided by expert laboratory information systems. In situ hybridization and immunohistochemistry for quantification will be largely digitalized as much as histology will be mostly digitalized rather than viewed using microscopy. Expert commentary: This review summarizes the technical and regulatory issues concerning the standardization of molecular tests in pathology. A vision of the future perspectives of technological changes is also provided.

AB - Introduction: Molecular tests that were once ancillary to the core business of cyto-histopathology are becoming the most relevant workload in pathology departments after histopathology/cytopathology and before autopsies. This has resulted from innovations in molecular biology techniques, which have developed at an incredibly fast pace. Areas covered: Most of the current widely used techniques in molecular pathology such as FISH, direct sequencing, pyrosequencing, and allele-specific PCR will be replaced by massive parallel sequencing that will not be considered next generation, but rather, will be considered to be current generation sequencing. The pre-analytical steps of molecular techniques such as DNA extraction or sample preparation will be largely automated. Moreover, all the molecular pathology instruments will be part of an integrated workflow that traces the sample from extraction to the analytical steps until the results are reported; these steps will be guided by expert laboratory information systems. In situ hybridization and immunohistochemistry for quantification will be largely digitalized as much as histology will be mostly digitalized rather than viewed using microscopy. Expert commentary: This review summarizes the technical and regulatory issues concerning the standardization of molecular tests in pathology. A vision of the future perspectives of technological changes is also provided.

KW - laboratory automation

KW - molecular pathology

KW - molecular pathology standardization

KW - Molecular tests

KW - regulations

UR - http://www.scopus.com/inward/record.url?scp=85006113553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006113553&partnerID=8YFLogxK

U2 - 10.1080/14737159.2017.1266258

DO - 10.1080/14737159.2017.1266258

M3 - Review article

C2 - 27897454

AN - SCOPUS:85006113553

VL - 17

SP - 47

EP - 55

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 1

ER -